Hongchen Biology
Latest round
- Angel
Last raised
- Oct 2024
Total raised
- Undisclosed
Investors
- 2
About Hongchen Biology
Established in 2023 and based in Wuhan, China, Hongchen Biology operates as a biotech company that mainly provides innovative stem cell medicine. The co-founder and chairman of the company, Jun Tong graduated from Huazhong University of Science and Technology. The company mainly provides innovative stem cell medicine. Products include autologous stem cell storage, IPSC-differentiated (Induced Pluripotent Stem Cell) mesenchymal stem cells, and MSC-derived (Mesenchymal Stem Cells) exosomes. The products are mainly used to treat spinal cord injuries. The company generates revenue by providing innovative stem cell medicine for the treatment of spinal cord injuries. The company will submit an IND application for a new drug for the treatment of spinal cord injury in H2 2025 and conduct a Phase I clinical trial in H1 2026.
Who invested in Hongchen Biology
2 investors across 1 round
See all investors in Hongchen Biology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Oct 18, 2024
Amount
Undisclosed
Investors
Questions about Hongchen Biology
Who invested in Hongchen Biology?
Hongchen Biology has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hongchen Biology raised?
Hongchen Biology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hongchen Biology last raise money?
Hongchen Biology's most recent round on record is a Angel, in Oct 2024.
What does Hongchen Biology do?
Established in 2023 and based in Wuhan, China, Hongchen Biology operates as a biotech company that mainly provides innovative stem cell medicine.
Where is Hongchen Biology headquartered?
Hongchen Biology is headquartered in Wuhan, China.
Which VCs invest in companies like Hongchen Biology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Hongchen Biology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Hongchen Biology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.